ISRCTN91790322已完成不适用
Randomised, double blind placebo controlled trial comparing Ibuprofen 600 mg three times per day versus placebo in the prevention of acute mountain sickness
niversity of Oxford (UK)0 个研究点目标入组 350 人开始时间: 2008年9月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy men or women between the ages of 18 and 65 without any current illness
- •2. Travelling directly to either Mount Everest Base camp or Kala Patthar
- •3. Not using any drugs for the prevention of altitude sickness or headache
排除标准
- •1. Younger than 18 years old or are 65 years or older
- •2. Going to Gokyo, Chukung Ri, or Island Peak before going to Kala Patthar or Everest base camp
- •3. Have altitude sickness, more than one mild symptom on the Lake Louise Questionnaire (LLQ) (see below), or significantly depressed oxygen saturation (less than 75%)
- •4. If female, either known to be pregnant or cannot exclude the possibility of being pregnant, or have missed menses by over 7 days
- •5. A known drug allergy to ibuprofen/motrin, naprosyn/naproxen or aspirin
- •6. Already stayed the night at an altitude of 4500 metres/14,000 feet within the last 9 days
- •7. Have taken any of the following in the last 2 days: acetazolamide (Diamox®), steroids (dexamethasone/decadron, prednisone), theophylline or diuretics (Lasix®)
- •8. Have taken any of the following within the last 8 hours: ibuprofen/motrin, naprosyn/naproxen, aspirin or acetaminophen
- •9. Any serious intracranial abnormalities such as history of brain tumours or pseudotumour cerebri
- •10. Have any known severe uncontrolled headache syndrome
研究者
相似试验
已完成
不适用
Randomised, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischaemiaAngina pectorisISRCTN58194927eiden University Medical Centre (LUMC) (The Netherlands)40
已完成
不适用
Randomised, double blind, placebo-controlled trial for testing the efficacy of a botanical formulation in reducing cold and flu symptomsCommon cold and fluInfections and InfestationsISRCTN09166218Radix Bioresearch Corporation (USA)60
已完成
不适用
Randomised double-blind, placebo-controlled trial of selenium supplementation in adult asthmaAdult asthmaRespiratoryAsthmaISRCTN31432640Department of Health (UK)200
进行中（未招募）
不适用
Randomized double blinde placebo controlled trial to evaluate the efficacy of N-acetylcystein in patients with chronic pancreatitis and primary sclerosing cholangitis.Chronic pancreatitis and primary sclerosing cholangitisMedDRA version: 15.0Level: PTClassification code 10033649Term: Pancreatitis chronicSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 15.0Level: PTClassification code 10008609Term: Cholangitis sclerosingSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2012-004170-26-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI200
进行中（未招募）
1 期
Randomised, double-blind, placebo controlled trial evaluating the effects of naloxone hydrochloride nasal spray on eating behaviours in bulimia nervosaMedDRA version: 20.0 Level: PT Classification code 10006550 Term: Bulimia nervosa System Organ Class: 10037175 - Psychiatric disordersBulimia nervosaEUCTR2016-003107-65-GBOpiant Pharmaceuticals Inc82